Medical impulsive therapy (MIT): the impact of 1 week of preoperative tamsulosin on deployment of 16-French ureteral access sheaths without preoperative ureteral stent placement
Introduction and objectives
Medical expulsive therapy is based on pharmacologic ureteral relaxation. We hypothesized this concept may facilitate the deployment of the large 16 French (F) ureteral access sheath (UAS) when patients are intentionally pre-treated with oral tamsulosin, i.e., medical impulsive therapy.
We retrospectively analyzed our experience with UAS deployment during endoscopic-guided percutaneous nephrolithotomy in prone position in patients pre-treated for 1 week with oral tamsulosin with a contemporary untreated cohort. Between January 2015 and September 2016, seventy-seven patients without a pre-existing ureteral stent met inclusion criteria. Demographic data, tamsulosin usage, UAS size, deployment failure, ureteral injuries, stone-free rates, and complications were recorded. Univariate and multivariate analysis was conducted to assess the impact of tamsulosin on deployment of the 16F UAS.
There was no statistical difference between the tamsulosin (n = 40) group and non-tamsulosin (n = 37) group in regard to demographic data. The tamsulosin group had a significantly higher percentage of 16F UAS deployment, 87 vs. 43% (p < 0.001), and no significant difference in ureteral injuries (p = 0.228). Univariate and multivariate analysis revealed that tamsulosin significantly increased the odds ratio (9.3 and 19.4, respectively) for successful passage of a 16F UAS. Despite a larger stone volume, there was no significant difference in computed tomography scan complete stone-free rates (29 vs. 42%; p = 0.277) at median post-operative time of only 3 days.
In this retrospective study, 1 week of preoperative tamsulosin was associated with an increase in the deployment of a 16F UAS in patients without preoperative ureteral stent placement.
KeywordsAlpha-blocker Tamsulosin Ureteral access sheath Ureteroscopy Nephrolithiasis
KSK: Project development, data collection and analysis, manuscript writing. SS: Data collection and analysis, manuscript writing. DL: Data collection and analysis, manuscript writing. EP: Data collection and analysis, manuscript writing. ZO: Project development, manuscript writing. YHK: Project development, statistical analysis, manuscript writing. LMH: Statistical analysis, manuscript writing. RMP: Project development, manuscript writing. JL: Project development, manuscript writing. RVC: Project development, manuscript writing.
Compliance with ethical standards
Conflicts of interest
The authors declare that they have no conflict of interest.
Research involving human participants and/or animals
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
Informed consent was obtained from all individual participants included in the study.
- 3.Ye Z, Zeng G, Yang H, Tang K, Zhang X, Li H et al (2017) Efficacy and safety of tamsulosin in medical expulsive therapy for distal ureteral stones with renal colic: a multicenter, randomized, double-blind, Placebo-controlled Trial. Eur Urol S0302–2838(17):30972–30977. https://doi.org/10.1016/j.eururo.2017.10.033 CrossRefGoogle Scholar
- 8.Traxer O, Wendt-Nordahl G, Sodha H et al (2015) Differences in renal stone treatment and outcomes for patients treated either with or without the support of a ureteral access sheath: The Clinical Research Office of the Endourological Society Ureteroscopy Global Study. World J Urol 33:2137–2144CrossRefPubMedPubMedCentralGoogle Scholar
- 23.Ito H, Kawahara T, Terao H et al (2013) Utility and limitation of cumulative stone diameter in predicting urinary stone burden at flexible ureteroscopy with holmium laser lithotripsy: a single-center experience. PLoS One 8:e65060. https://doi.org/10.1371/journal.pone.0065060 CrossRefPubMedPubMedCentralGoogle Scholar
- 25.Bone RC, Balk RA, Cerra FB et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101(6):1644–1655CrossRefPubMedGoogle Scholar
- 28.Anon (2006) Flomax (tamsulosin hydrochloride) capsules, 0.4 mg prescribing information. http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020579s016lbl.pdf. Accessed 20 Feb 2017